Class Action

DayQuil Medicines with DXM

Class Action

DayQuil Medicines with DXM


Case Name (Date)

Clay et al. v. The Procter & Gamble Co.
21-cv-11133, S.D.N.Y.
(Dec. 2021)


Product/Service

DayQuil medicines containing dextromethorphan hydrobromide (DXM)\


Allegations

Misleadingly marketing medicines as “non-drowsy” when an ingredient in them causes drowsiness


Status

Pending



Class-Action Tracker

DayQuil Super C

Class Action

DayQuil Super C

Allegations: Misleadingly marketing products as if they alleviate cold and flu symptoms when fine print on the side of the product packaging discloses that the products are “not intended to…


The Latest

Filters

Gillette Engaged in Deceptive Made in USA Marketing

Press Release

Gillette Engaged in Deceptive Made in USA Marketing

Ad Watchdog TINA.org Files FTC Complaint MADISON, CONN. January 23, 2018 – Despite a national advertising campaign showcasing patriotic imagery, highlighting its Boston headquarters, and heavily promoting its “Made in…


Show More